High-dose versus standard-dose rituximab with BEAM in autologous stem cell transplantation (SCT) for relapsed aggressive b-cell non-Hodgkin's lymphomas (NHL).

被引：0
|
作者：
Srour, Samer Ali [1 ]
Khouri, Issa F. [1 ]
Nieto, Yago [1 ]
Popat, Uday R. [1 ]
Qazilbash, Muzaffar H. [1 ]
Anderlini, Paolo [1 ]
Kebriaei, Partow [1 ]
Shpall, Elizabeth J. [1 ]
Champlin, Richard E. [1 ]
Hosing, Chitra [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.7524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7524
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin's lymphoma
    Hess, Georg
    Flohr, Thomas
    Kolbe, Karin
    Bonn, Sarah
    Schuler, Martin
    Derigs, Hans Guenter
    Huber, Christoph
    ANNALS OF HEMATOLOGY, 2006, 85 (11) : 769 - 779
  • [42] Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin’s lymphoma
    Georg Hess
    Thomas Flohr
    Karin Kolbe
    Sarah Bonn
    Martin Schuler
    Hans Günter Derigs
    Christoph Huber
    Annals of Hematology, 2006, 85 : 769 - 779
  • [43] Single or double autologous stem cell transplantation for transformed aggressive B-cell non-Hodgkin's lymphoma
    Clavert, A.
    Roland, V.
    Le Gouill, S.
    Dubruille, V.
    Mahe, B.
    Gastinne, T.
    Blin, N.
    Chevallier, P.
    Guillaume, T.
    Delaunay, J.
    Ayari, S.
    Devys, A.
    Flandrois, G.
    Saulquin, B.
    Moreau, A.
    Moreau, P.
    Harousseau, J. L.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S211 - S211
  • [44] Treosulfan-based tandem high-dose chemo-immuno-therapy with autologous stem cell transplantation for relapsed and refractory aggressive B-cell lymphomas.
    Reichle, A
    Holler, E
    Berand, A
    Andreesen, R
    BLOOD, 2005, 106 (11) : 460B - 460B
  • [45] High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma:: results of a multicenter phase II study
    Josting, A
    Sieniawski, M
    Glossmann, JP
    Staak, O
    Nogova, L
    Peters, N
    Mapara, M
    Dörken, B
    Ko, Y
    Metzner, B
    Kisro, J
    Diehl, V
    Engertl, A
    ANNALS OF ONCOLOGY, 2005, 16 (08) : 1359 - 1365
  • [46] Phase I clinical trial of Zevalin (90Y-ibritumomab) in patients with B-cell non-Hodgkin's lymphoma (NHL) with relapsed disease following high-dose chemotherapy and autologous stem cell transplantation (ASCT).
    Vose, JM
    Bierman, PJ
    Lynch, JC
    Bociek, GR
    Multani, PS
    Armitage, JO
    BLOOD, 2003, 102 (11) : 30A - 30A
  • [47] International Consensus Conference on High-Dose Therapy with Hematopoietic Stem-Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: Report of jury
    Shipp, MA
    Abeloff, MD
    Antman, KH
    Carroll, G
    Hagenbeek, A
    Loeffler, M
    Montserrat, E
    Radford, JA
    Salles, G
    Schmitz, N
    Symann, M
    Armitage, JO
    Coiffier, B
    Philip, T
    ANNALS OF ONCOLOGY, 1999, 10 (01) : 13 - 19
  • [48] New drugs for B-cell non-Hodgkin's lymphomas (NHL)
    Cheson, B. D.
    ANNALS OF ONCOLOGY, 2008, 19 : 127 - 127
  • [49] High dose therapy and autologous stem cell transplantation in follicular non-Hodgkin's lymphoma
    Freedman, AS
    Gribben, JG
    Nadler, LM
    LEUKEMIA & LYMPHOMA, 1998, 28 (3-4) : 219 - 230
  • [50] High-dose infusional ifosfamide, etoposide plus methylprednisolone followed by dexamethasone, high-dose ara-C and cisplatinum and autologous stem cell transplantation for refractory or relapsed aggressive non-Hodgkin's lymphoma
    Salar, A
    Martino, R
    Perea, G
    Ribera, JM
    López-Guillermo, A
    Guardia, R
    Escoda, L
    Altés, A
    Sierra, J
    Montserrat, E
    HAEMATOLOGICA, 2002, 87 (10) : 1028 - 1035
12345